Skip to content
Rio de Janeiro · São Paulo · Salvador — matters across Brazil
Bruno Marcelos — Escritório de Advocacia

Pauta Regulatória · Daily brief

No. 126

Automatically translated from the Portuguese edition, which prevails in case of discrepancy. Ler em português

Federal Official Gazette

No changes.

ANS news

ANS supports national survey on health and well-being in organizations

Survey seeks to map practices and challenges in companies and institutions across the country

https://www.gov.br/ans/pt-br/assuntos/noticias/qualidade-da-saude/ans-apoia-pesquisa-nacional-sobre-saude-e-bem-estar-nas-organizacoes

ANS clarifies that absence of a code does not justify denial of coverage or reimbursement

Guidance reinforces that the number is an administrative instrument and cannot restrict rights provided for in the List of Health Procedures and Events (Rol) or in the health plan contract

https://www.gov.br/ans/pt-br/assuntos/noticias/beneficiario/ans-esclarece-que-ausencia-de-codigo-nao-justifica-negativa-de-cobertura-ou-reembolso

ANS highlights: Law No. 15,378 establishes the Patient Rights Statute

The legislation represents a milestone in protecting the rights of users of public or private health systems.

https://www.gov.br/ans/pt-br/assuntos/noticias/beneficiario/ans-destaca-lei-no-15-378-institui-estatuto-dos-direitos-do-paciente

ANS opens registration for the Comprehensive Care for Pregnant Women and Newborns Project

The goal is to improve the quality of maternal and neonatal health care

https://www.gov.br/ans/pt-br/assuntos/noticias/qualidade-da-saude/ans-abre-inscricoes-para-o-projeto-cuidado-integral-a-gestante-e-ao-neonato

Open public consultations

  • CP 170. Update of the regulation of the relationship between private health care plan operators and health care service providers. Deadline: Apr 1, 2026 to May 16, 2026.
  • CP 171. Aims to receive contributions on the proposed updates to the List of Health Procedures and Events (Rol). Deadline: from Apr 9, 2026 to May 28, 2026.

Scheduled public hearings

  • Public Hearing No. 65, collection of contributions on a preliminary recommendation against incorporation for the following technology:
    UAT 183 – Evolocumab for the treatment of hypercholesterolemia in adult patients who have suffered a recent severe atherosclerotic cardiovascular event (50 mg/dL). Date: April 17, 2026, from 09:30 to 11:00.

Open public calls for input

There is no open public call for input.

Open public calls

No updates.

Other news

– No updates.

Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.